Available from: Lam CS, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM
*Correspondence: Yuying Fan [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Multiple CDMOs are active in drug production, including Corden Pharma (Astorg), Axplora (Bridgepoint) and AmbioPharma (Carlyle)
3) patients were excluded who already had tumors before GLP-1RA therapy, and GLP-1RA was reported as the primary suspect drug in all cases on the basis of model 2
And remember that the dosage, ingredient, and source information on the bottle may not be completely accurate